Advice
Following a resubmission.
Standardised allergen extract of grass pollen 75,000 SQ-T per oral lyophilisate (Grazax®) is not recommended for use within NHS Scotland for the treatment of grass pollen induced rhinitis and conjunctivitis in adult patients with clinically relevant symptoms and diagnosed with a positive skin prick test and/or specific IgE test to grass pollen.
Although modest clinical benefit has been shown, the manufacturer did not present a sufficiently robust economic analysis to gain acceptance by SMC.
Download detailed advice101KB (PDF)
Medicine details
- Medicine name:
- standardised allergen extract of grass pollen from Timothy (Phleum pratense) 75,000 SQ-T per oral lyophilisate
- SMC ID:
- 367/07
- Indication:
- Grass pollen induced rhinitis and conjunctivitis in adult patients
- Pharmaceutical company
- ALK-Abello Ltd
- BNF chapter
- Respiratory system
- Submission type
- Resubmission
- Status
- Not recommended
- Date advice published
- 14 January 2008